DUKE UNIVERSITY - BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS

On Jan 23, 2026, Department of Health and Human Services obligated $8,783,682 to DUKE UNIVERSITY for bpca innovative trial designs and assay developments in pediatric therapeutics. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Sep 27, 2027 — approximately 13 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.